|
⚲
|
| Keyboard |
| Column Group Opportunity III GP LP
✚
|
|
|---|---|
| CIK # | 0001932874 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001932874] | |
| 4 | [0001932874] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-25 | Sell | 1,649,281 | $0.56 | 923,597 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-25 | Sell | 1,862,545 | $0.56 | 1,043,025 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-24 | Sell | 349,212 | $0.62 | 216,511 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-24 | Sell | 309,228 | $0.62 | 191,721 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-23 | Sell | 143,709 | $0.60 | 86,225 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-23 | Sell | 162,291 | $0.60 | 97,375 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-20 | Sell | 245,965 | $0.61 | 150,039 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-20 | Sell | 277,769 | $0.61 | 169,439 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-11 | Sell | 1,905,115 | $0.68 | 1,295,478 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-11 | Sell | 2,151,458 | $0.68 | 1,462,991 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-10 | Sell | 182,295 | $0.82 | 149,482 |
|
Tenaya Therapeutics Inc TNYA
Common Stock
|
2026-02-10 | Sell | 161,422 | $0.82 | 132,366 |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 1,296,629 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Buy | 1,437,323 | $18.00 | 25,871,814 |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Buy | 49,556 | $18.00 | 892,008 |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 3,785 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 688,283 | ||
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 10,467,526 | ||
|
Eikon Therapeutics Inc EIKN
Series A Preferred Stock · derivative
|
2026-02-06 | Conversion | 330,000 | ||
|
Eikon Therapeutics Inc EIKN
Series C-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 827,278 | ||
| showing 20 of 110 most recent transactions | |||||